Differences in Clinical and Biological Features Between Type I and Type II Tumors in FIGO Stages I-II Epithelial Ovarian Carcinoma

Por Skirnisdottir, Ingiridur, Seidal, Tomas, Åkerud, Helena
Publicado no Int J Gynecol Cancer (2015)

The relationship of the angiogenesis regulators VEGF-A, VEGF-R1 and VEGF-R2 to p53 status and prognostic factors in epithelial ovarian carcinoma in FIGO-stages I–II

Por SKIRNISDOTTIR, INGIRIDUR, SEIDAL, TOMAS, ÅKERUD, HELENA
Publicado no Int J Oncol (2016)

Napsin A as a marker of clear cell ovarian carcinoma

Por Skirnisdottir, Ingiridur, Bjersand, Kathrine, Åkerud, Helena, Seidal, Tomas
Publicado no BMC Cancer (2013)

Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease

Por Skirnisdottir Ingiridur, Mayrhofer Markus, Rydåker Maria, Åkerud Helena, Isaksson Anders
Publicado em 2012-09-01

Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease

Por Skirnisdottir, Ingiridur, Mayrhofer, Markus, Rydåker, Maria, Åkerud, Helena, Isaksson, Anders
Publicado em 2012

The clinical and prognostic correlation of HRNPM and SLC1A5 in pathogenesis and prognosis in epithelial ovarian cancer

Por Bjersand, Kathrine, Seidal, Tomas, Sundström-Poromaa, Inger, Åkerud, Helena, Skirnisdottir, Ingiridur
Publicado no PLoS One (2017)